ABBOTT (1)

Akognos (3)

ALEKM (2)

Alniche Life (6)

Aprazer (45)

Astellas (4)

Bayer (2)

Bharat Serums (1)

BIOCON (13)

Bios Lab (1)

Boehringer Ingelheim (3)

CIPLA (18)

Concord Biotech (13)

Dr. Reddy’s (2)

Emcure (4)

FRESENIUS KABI (1)

GLAXO (6)

GLENMARK (3)

HETERO (6)

Intas (6)

La Renon (1)

Mediart (2)

MIRACALUS (4)

MYLAN (11)

NATCO (31)

Novartis India  (8)

Panacea Biotec (11)

PFIZER (3)

ROCHE (5)

RPG Life Science (1)

Steadfast (6)

Sunlife Sciences (2)

Wockhardt (4)

ZYDUS CADILA (16)

The Brand  pharmaceutical industry

As of 2002, over 20,000 registered drug-manufacturers in India sold $9 billion worth of formulations and bulk drugs. 85% of these formulations were sold in India while over 60% of the bulk drugs were exported, mostly to the United States and to Russia. Most of the players in the market are small-to-medium enterprises; 250 of the largest companies control 70% of the Indian market.Thanks to the 1970 Patent Act, multinationals represent only 35% of the market, down from 70% thirty years ago